JUAN CARLOS
NIETO GONZÁLEZ
Profesor asociado de Ciencias de la Salud
LUIS
CARREÑO PÉREZ
Investigador fins a 2015
Publicacions en què col·labora amb LUIS CARREÑO PÉREZ (11)
2016
-
Multiobserver reliability of ultrasound assessment of salivary glands in patients with established primary sjögren syndrome
Journal of Rheumatology, Vol. 43, Núm. 10, pp. 1858-1863
-
Structural damage in rheumatoid arthritis: Comparison between tendon damage evaluated by ultrasound and radiographic damage
Rheumatology (United Kingdom), Vol. 55, Núm. 6, pp. 1042-1046
-
Ultrasound-detected activity in rheumatoid arthritis on methotrexate therapy: Which joints and tendons should be assessed to predict unstable remission?
Rheumatology International, Vol. 36, Núm. 3, pp. 387-396
2015
-
Comparison between full and tapered dosages of biologic therapies in psoriatic arthritis patients: clinical and ultrasound assessment
Clinical Rheumatology, Vol. 34, Núm. 5, pp. 935-942
-
Impact of musculoskeletal ultrasound on clinical practice in paediatric rheumatology
Clinical and Experimental Rheumatology, Vol. 33, Núm. 4, pp. 583-587
-
Investigating the link between disease activity and infliximab serum levels in rheumatoid arthritis patients
Clinical and Experimental Rheumatology, Vol. 33, Núm. 6, pp. 805-811
-
Juvenile, adult and late-onset systemic lupus erythematosus: A long-term follow-up study from a geographic and ethnically homogeneous population
Clinical and Experimental Rheumatology, Vol. 33, Núm. 6, pp. 788-794
2014
-
Does ultrasound-scored synovitis depend on the pharmacokinetics of subcutaneous anti-TNF agents in patients with rheumatoid arthritis?
Rheumatology (United Kingdom), Vol. 53, Núm. 11, pp. 2088-2094
-
Minimum Effective Dosages of Anti-TNF in Rheumatoid Arthritis: A Cross-sectional Study
Reumatologia Clinica, Vol. 10, Núm. 2, pp. 101-104
-
Salivary gland ultrasound in children: A useful tool in the diagnosis of juvenile Sjögren's syndrome
Clinical and Experimental Rheumatology, Vol. 32, Núm. 4, pp. 578-580
2013
-
Anti-TNF treatments in rheumatoid arthritis: Economic impact of dosage modification
Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 13, Núm. 3, pp. 407-414